← Browse by Condition
Medical Condition

recurrent lung non small cell carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05642572 Phase 2
Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →